Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SCO-267

Copy Product Info
😃Good
Catalog No. T39140Cas No. 1656261-09-4
Alias SCO267

SCO-267 is a full agonist of GPR40/FFAR1 with an EC50 of 12 nM, effectively stimulating insulin secretion and GLP-1 release in diabetic rats, improving glucose tolerance, and can be used for the treatment of type 2 diabetes.

SCO-267

SCO-267

Copy Product Info
😃Good
Purity: 99.89%
Catalog No. T39140Alias SCO267Cas No. 1656261-09-4
SCO-267 is a full agonist of GPR40/FFAR1 with an EC50 of 12 nM, effectively stimulating insulin secretion and GLP-1 release in diabetic rats, improving glucose tolerance, and can be used for the treatment of type 2 diabetes.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$139-In Stock
5 mg$359-In Stock
10 mg$587-In Stock
25 mg$1,170-In Stock
50 mg$1,890-In Stock
1 mL x 10 mM (in DMSO)$486-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.89%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
SCO-267 is a full agonist of GPR40/FFAR1 with an EC50 of 12 nM, effectively stimulating insulin secretion and GLP-1 release in diabetic rats, improving glucose tolerance, and can be used for the treatment of type 2 diabetes.
In vitro
Method:
The activation of G protein-coupled receptor signaling pathways by SCO-267 was evaluated in CHO cells, including Gαq, Gαs, Gα12/13 pathways and β-arrestin recruitment. Its allosteric interaction with fasiglifam and an endogenous ligand was also analyzed.[1]

Result:
SCO-267 activated the Gαq, Gαs, and Gα12/13 pathways and induced β-arrestin recruitment. It exhibited allosteric modulation with fasiglifam and an endogenous ligand.[1]
In vivo
Method:
In the N-STZ rat model, SCO-267 was administered orally at doses of 1 or 10 mg/kg to evaluate its effects on insulin sensitivity and blood glucose levels.

Result:
SCO-267 improved insulin sensitivity and exerted a sustained glucose-lowering effect. [1]
SynonymsSCO267
Chemical Properties
Molecular Weight614.77
FormulaC36H46N4O5
Cas No.1656261-09-4
SmilesC(N(CC(C)(C)C)C=1N=C(C)C=CC1)(=O)C2=C(C=C(OC)C=C2)N3CCC(COC4=CC([C@@H](CC(O)=O)[C@@H]5CC5)=CC=N4)CC3
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (130.13 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 3.3 mg/mL (5.37 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6266 mL8.1331 mL16.2662 mL81.3312 mL
5 mM0.3253 mL1.6266 mL3.2532 mL16.2662 mL
10 mM0.1627 mL0.8133 mL1.6266 mL8.1331 mL
20 mM0.0813 mL0.4067 mL0.8133 mL4.0666 mL
50 mM0.0325 mL0.1627 mL0.3253 mL1.6266 mL
100 mM0.0163 mL0.0813 mL0.1627 mL0.8133 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SCO-267 | purchase SCO-267 | SCO-267 cost | order SCO-267 | SCO-267 chemical structure | SCO-267 in vivo | SCO-267 in vitro | SCO-267 formula | SCO-267 molecular weight